162 related articles for article (PubMed ID: 20530713)
1. Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2.
Tang JZ; Kong XJ; Kang J; Fielder GC; Steiner M; Perry JK; Wu ZS; Yin Z; Zhu T; Liu DX; Lobie PE
Mol Cancer Ther; 2010 Jun; 9(6):1697-708. PubMed ID: 20530713
[TBL] [Abstract][Full Text] [Related]
2. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
[TBL] [Abstract][Full Text] [Related]
3. Artemin stimulates oncogenicity and invasiveness of human endometrial carcinoma cells.
Pandey V; Qian PX; Kang J; Perry JK; Mitchell MD; Yin Z; Wu ZS; Liu DX; Zhu T; Lobie PE
Endocrinology; 2010 Mar; 151(3):909-20. PubMed ID: 20118197
[TBL] [Abstract][Full Text] [Related]
4. Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma.
Kang J; Qian PX; Pandey V; Perry JK; Miller LD; Liu ET; Zhu T; Liu DX; Lobie PE
Oncogene; 2010 Jun; 29(22):3228-40. PubMed ID: 20305694
[TBL] [Abstract][Full Text] [Related]
5. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
[TBL] [Abstract][Full Text] [Related]
6. Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells.
Banerjee A; Qian P; Wu ZS; Ren X; Steiner M; Bougen NM; Liu S; Liu DX; Zhu T; Lobie PE
J Biol Chem; 2012 Dec; 287(51):42502-15. PubMed ID: 23095743
[TBL] [Abstract][Full Text] [Related]
7. Artemin is oncogenic for human mammary carcinoma cells.
Kang J; Perry JK; Pandey V; Fielder GC; Mei B; Qian PX; Wu ZS; Zhu T; Liu DX; Lobie PE
Oncogene; 2009 May; 28(19):2034-45. PubMed ID: 19363524
[TBL] [Abstract][Full Text] [Related]
8. miR-223 regulates migration and invasion by targeting Artemin in human esophageal carcinoma.
Li S; Li Z; Guo F; Qin X; Liu B; Lei Z; Song Z; Sun L; Zhang HT; You J; Zhou Q
J Biomed Sci; 2011 Mar; 18(1):24. PubMed ID: 21453483
[TBL] [Abstract][Full Text] [Related]
9. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma.
Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T
Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549
[TBL] [Abstract][Full Text] [Related]
10. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
11. Artemin promotes oncogenicity, metastasis and drug resistance in cancer cells.
Hezam K; Jiang J; Sun F; Zhang X; Zhang J
Rev Neurosci; 2018 Jan; 29(1):93-98. PubMed ID: 28937965
[TBL] [Abstract][Full Text] [Related]
12. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
13. The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.
Chen WL; Kuo KT; Chou TY; Chen CL; Wang CH; Wei YH; Wang LS
BMC Cancer; 2012 Jun; 12():273. PubMed ID: 22748147
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation.
Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D
Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180
[TBL] [Abstract][Full Text] [Related]
15. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT.
Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J
J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2.
Jin JJ; Liu YH; Si JM; Ni R; Wang J
Int J Biochem Cell Biol; 2018 Feb; 95():113-120. PubMed ID: 29275213
[TBL] [Abstract][Full Text] [Related]
17. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
18. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
19. Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.
Tan X; Zhou F; Wan J; Hang J; Chen Z; Li B; Zhang C; Shao K; Jiang P; Shi S; Feng X; Lv N; Wang Z; Ling Y; Zhao X; Ding D; Sun J; Xiong M; He J
Cancer Biol Ther; 2010 Jan; 9(2):111-9. PubMed ID: 20009523
[TBL] [Abstract][Full Text] [Related]
20. ARTEMIN Promotes Oncogenicity and Resistance to 5-Fluorouracil in Colorectal Carcinoma by p44/42 MAPK Dependent Expression of CDH2.
Zhuang QS; Sun XB; Chong QY; Banerjee A; Zhang M; Wu ZS; Zhu T; Pandey V; Lobie PE
Front Oncol; 2021; 11():712348. PubMed ID: 34422665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
